Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Submitted by
admin
on October 2, 2009 - 10:38am
Source:
Yahoo/AP
News Tags:
Bristol-Myers Squibb
AstraZeneca
diabetes
Dapagliflozin
Headline:
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Do Not Allow Advertisers to Use My Personal information
